124 related articles for article (PubMed ID: 2903466)
1. [Clinical experimentation with a new antihistaminic molecule in allergic conjunctivitis].
Hesse A; Reggiardo F; Satragno L; Rivara A
Minerva Med; 1988 Oct; 79(10):883-6. PubMed ID: 2903466
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of astemizole in allergic conjunctivitis].
Favennec DF
Allerg Immunol (Paris); 1989 Jun; 21(6):243-6. PubMed ID: 2569877
[TBL] [Abstract][Full Text] [Related]
3. [Role of antihistaminics in the treatment of allergic conjunctivitis].
Lods F
Bull Soc Ophtalmol Fr; 1988; 88(8-9):1093-5. PubMed ID: 2907982
[No Abstract] [Full Text] [Related]
4. Clinical profile of astemizole. A survey of 50 double-blind trials.
Vanden Bussche G; Emanuel MB; Rombaut N
Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
[TBL] [Abstract][Full Text] [Related]
5. [A new H1-blocking antihistamine. Critical review of pharmacological and clinical studies].
Emmi L; Rossi O
Minerva Med; 1988 Mar; 79(3):219-27. PubMed ID: 2896316
[TBL] [Abstract][Full Text] [Related]
6. Practical therapeutics: the use of histamine receptor antagonists in contemporary times.
Obel AO
East Afr Med J; 1984 Jul; 61(7):578-82. PubMed ID: 6152737
[No Abstract] [Full Text] [Related]
7. [Bilastine [Bellozal), oral].
Duh D; Tanret I
J Pharm Belg; 2012 Dec; (4):53-4. PubMed ID: 23350212
[No Abstract] [Full Text] [Related]
8. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
Endre L
Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of urticaria with the new H1 antihistaminic astemizole--with special reference to the time of onset of effect and maximum effect].
Kurz K
Z Hautkr; 1986 Nov; 61(22):1646-53. PubMed ID: 2880431
[TBL] [Abstract][Full Text] [Related]
10. Treatment of allergic rhinitis with a new long-acting H1 receptor antagonist: astemizole.
Sooknundun M; Kacker SK; Sundaram KR
Ann Allergy; 1987 Jan; 58(1):78-81. PubMed ID: 2879487
[No Abstract] [Full Text] [Related]
11. A double-blind study of astemizole and terfenadine in the treatment of perennial rhinitis.
Boland N
Ann Allergy; 1988 Jul; 61(1):18-24. PubMed ID: 2898906
[No Abstract] [Full Text] [Related]
12. Blocking of histamine-induced conjunctivitis by the oral antihistamine, astemizole.
Stokes TC; Feinberg G
Br J Clin Pharmacol; 1988 Jun; 25(6):771-3. PubMed ID: 2904824
[TBL] [Abstract][Full Text] [Related]
13. Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels.
Howarth PH; Emanuel MB; Holgate ST
Br J Clin Pharmacol; 1984 Jul; 18(1):1-8. PubMed ID: 6146346
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of chronic urticaria with a new synthetic antihistamine: astemizole].
Annunziata M; Aimo Boot D
G Ital Dermatol Venereol; 1984; 119(5):XVII-XX. PubMed ID: 6150894
[No Abstract] [Full Text] [Related]
15. [Treatment of allergic rhinitis in children with a new antihistamine].
Pérez Martín J; Madariaga Márquez JB; Ortega Gómez H
Alergia; 1985; 32(2):45-9. PubMed ID: 2863994
[No Abstract] [Full Text] [Related]
16. The development of a new antihistamine: astemizole.
Ray JA
N Engl Reg Allergy Proc; 1985; 6(1):71-7. PubMed ID: 2888010
[TBL] [Abstract][Full Text] [Related]
17. [Astemizole in the treatment of acute rhinopharyngitis (common cold). A double-blind study in pediatrics].
Hugenin M; Martin Du Pan R; Oppikofer-Doody AM
Rev Med Suisse Romande; 1988 Nov; 108(11):961-6. PubMed ID: 2905068
[No Abstract] [Full Text] [Related]
18. Potential of interaction between the H1-antagonist astemizole and other drugs.
Rombaut N; Heykants J; Vanden Bussche G
Ann Allergy; 1986 Nov; 57(5):321-4. PubMed ID: 2877601
[TBL] [Abstract][Full Text] [Related]
19. [An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
Stara J; Krásný J; Plísková S; Síblová O
Cesk Slov Oftalmol; 1997 Feb; 53(1):46-8. PubMed ID: 9213524
[TBL] [Abstract][Full Text] [Related]
20. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
